Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Accenture
Julphar
AstraZeneca
Moodys
Express Scripts
Baxter
Colorcon
UBS

Generated: January 23, 2019

DrugPatentWatch Database Preview

Drug Price Trends for SYMLIN

« Back to Dashboard

Average Pharmacy Cost for SYMLIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
SYMLINPEN 120 PEN INJECTOR 00310-6627-02 194.17440 ML 2019-01-01
SYMLINPEN 60 PEN INJECTOR 00310-6615-02 293.46500 ML 2019-01-01
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Federal Trade Commission
Accenture
Daiichi Sankyo
Healthtrust
Colorcon
Merck
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.